Literature DB >> 21931173

Setleis syndrome in Mexican-Nahua sibs due to a homozygous TWIST2 frameshift mutation and partial expression in heterozygotes: review of the focal facial dermal dysplasias and subtype reclassification.

David E Cervantes-Barragán1, Camilo E Villarroel, Alma Medrano-Hernández, Carola Durán-McKinster, Vanessa Bosch-Canto, Victoria Del-Castillo, Irina Nazarenko, Amy Yang, Robert J Desnick.   

Abstract

BACKGROUND: The focal facial dermal dysplasias (FFDDs) are a group of inherited disorders of facial development, characterised by bitemporal or preauricular scar-like defects, the former resembling 'forceps marks'. Recently, different homozygous TWIST2 nonsense mutations were reported in unrelated Setleis syndrome (FFDD Type III) patients from consanguineous families, consistent with autosomal recessive inheritance. Mexican-Nahua sibs with facial and ophthalmologic features of FFDD type III were evaluated.
METHODS: Genomic DNAs were isolated for sequencing of the TWIST2 gene. The clinical features and inheritance of all previously reported FFDD patients were reviewed.
RESULTS: The affected sibs were homozygous for a novel TWIST2 frameshift mutation, c.168delC (p.S57AfsX45). Notably, both parents and two heterozygous sibs had distichiasis and partial absence of lower eyelashes. The FFDD subtypes were reclassified: the 'Brauer-Setleis' phenotype (autosomal dominant with variable expressivity) as FFDD type II; and patients with preauricular lesions as a new subtype, FFDD type IV.
CONCLUSIONS: FFDD type III heterozygotes with TWIST2 mutations may have syndromic manifestations. Review of previous FFDD patients resulted in reclassification of the subtypes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21931173     DOI: 10.1136/jmedgenet-2011-100251

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  9 in total

1.  Setleis syndrome due to inheritance of the 1p36.22p36.21 duplication: evidence for lack of penetrance.

Authors:  Beom Hee Lee; Christos Kasparis; Brenden Chen; Hui Mei; Lisa Edelmann; Celia Moss; David D Weaver; Robert J Desnick
Journal:  J Hum Genet       Date:  2015-08-27       Impact factor: 3.172

2.  A novel frameshift mutation in TWIST2 gene causing Setleis syndrome.

Authors:  Katta Mohan Girisha; Abdul Mueed Bidchol; Murali Keshava Sarpangala; Kapaettu Satyamoorthy
Journal:  Indian J Pediatr       Date:  2013-10-15       Impact factor: 1.967

3.  Focal facial dermal dysplasia, type IV, is caused by mutations in CYP26C1.

Authors:  Anne M Slavotinek; Pavni Mehrotra; Irina Nazarenko; Paul Ling-Fung Tang; Richard Lao; Don Cameron; Ben Li; Catherine Chu; Chris Chou; Ann L Marqueling; Mani Yahyavi; Kelly Cordoro; Ilona Frieden; Tom Glaser; Trine Prescott; Marie-Anne Morren; Koen Devriendt; Pui-yan Kwok; Martin Petkovich; Robert J Desnick
Journal:  Hum Mol Genet       Date:  2012-11-16       Impact factor: 6.150

4.  Recurrent Mutations in the Basic Domain of TWIST2 Cause Ablepharon Macrostomia and Barber-Say Syndromes.

Authors:  Shannon Marchegiani; Taylor Davis; Federico Tessadori; Gijs van Haaften; Francesco Brancati; Alexander Hoischen; Haigen Huang; Elise Valkanas; Barbara Pusey; Denny Schanze; Hanka Venselaar; Anneke T Vulto-van Silfhout; Lynne A Wolfe; Cynthia J Tifft; Patricia M Zerfas; Giovanna Zambruno; Ariana Kariminejad; Farahnaz Sabbagh-Kermani; Janice Lee; Maria G Tsokos; Chyi-Chia R Lee; Victor Ferraz; Eduarda Morgana da Silva; Cathy A Stevens; Nathalie Roche; Oliver Bartsch; Peter Farndon; Eva Bermejo-Sanchez; Brian P Brooks; Valerie Maduro; Bruno Dallapiccola; Feliciano J Ramos; Hon-Yin Brian Chung; Cédric Le Caignec; Fabiana Martins; Witold K Jacyk; Laura Mazzanti; Han G Brunner; Jeroen Bakkers; Shuo Lin; May Christine V Malicdan; Cornelius F Boerkoel; William A Gahl; Bert B A de Vries; Mieke M van Haelst; Martin Zenker; Thomas C Markello
Journal:  Am J Hum Genet       Date:  2015-06-25       Impact factor: 11.025

5.  Focal facial dermal dysplasia type 4: identification of novel CYP26C1 mutations in unrelated patients.

Authors:  Beom Hee Lee; Fanny Morice-Picard; Franck Boralevi; Brenden Chen; Robert J Desnick
Journal:  J Hum Genet       Date:  2017-12-20       Impact factor: 3.172

6.  Setleis syndrome: clinical, molecular and structural studies of the first TWIST2 missense mutation.

Authors:  R Ozgur Rosti; Z Oya Uyguner; Irina Nazarenko; Mehmet Bekerecioglu; Carmen L Cadilla; Hilal Ozgur; Beom Hee Lee; Aneel K Aggarwal; Sacide Pehlivan; Robert J Desnick
Journal:  Clin Genet       Date:  2014-12-11       Impact factor: 4.438

7.  Phenotypic variant of Brachydactyly-mental retardation syndrome in a family with an inherited interstitial 2q37.3 microdeletion including HDAC4.

Authors:  Pablo Villavicencio-Lorini; Eva Klopocki; Marc Trimborn; Randi Koll; Stefan Mundlos; Denise Horn
Journal:  Eur J Hum Genet       Date:  2012-11-28       Impact factor: 4.246

8.  Expression Profiling Identifies TWIST2 Target Genes in Setleis Syndrome Patient Fibroblast and Lymphoblast Cells.

Authors:  Noe E Crespo; Alexandra Torres-Bracero; Jessicca Y Renta; Robert J Desnick; Carmen L Cadilla
Journal:  Int J Environ Res Public Health       Date:  2021-02-19       Impact factor: 3.390

9.  Novel insights into the bovine polled phenotype and horn ontogenesis in Bovidae.

Authors:  Aurélie Allais-Bonnet; Cécile Grohs; Ivica Medugorac; Stefan Krebs; Anis Djari; Alexander Graf; Sébastien Fritz; Doris Seichter; Aurélia Baur; Ingolf Russ; Stéphan Bouet; Sophie Rothammer; Per Wahlberg; Diane Esquerré; Chris Hoze; Mekki Boussaha; Bernard Weiss; Dominique Thépot; Marie-Noëlle Fouilloux; Marie-Noëlle Rossignol; Este van Marle-Köster; Gunnfríður Elín Hreiðarsdóttir; Sarah Barbey; Dominique Dozias; Emilie Cobo; Patrick Reversé; Olivier Catros; Jean-Luc Marchand; Pascal Soulas; Pierre Roy; Brigitte Marquant-Leguienne; Daniel Le Bourhis; Laetitia Clément; Laura Salas-Cortes; Eric Venot; Maëlle Pannetier; Florence Phocas; Christophe Klopp; Dominique Rocha; Michel Fouchet; Laurent Journaux; Carine Bernard-Capel; Claire Ponsart; André Eggen; Helmut Blum; Yves Gallard; Didier Boichard; Eric Pailhoux; Aurélien Capitan
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.